2E59
Crystal structure of human MD-2 in complex with lipid IVa
Summary for 2E59
Entry DOI | 10.2210/pdb2e59/pdb |
Related | 2E56 |
Descriptor | Lymphocyte antigen 96, 2-acetamido-2-deoxy-beta-D-glucopyranose, (R)-((2R,3S,4R,5R,6R)-3-HYDROXY-2-(HYDROXYMETHYL)-5-((R)-3-HYDROXYTETRADECANAMIDO)-6-(PHOSPHONOOXY)TETRAHYDRO-2H-PYRAN-4-YL) 3-HYDROXYTETRADECANOATE, ... (5 entities in total) |
Functional Keywords | innate immunity, lipid-binding, lipid binding protein |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 1 |
Total formula weight | 18452.27 |
Authors | |
Primary citation | Ohto, U.,Fukase, K.,Miyake, K.,Satow, Y. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa Science, 316:1632-1634, 2007 Cited by PubMed Abstract: Endotoxic lipopolysaccharide (LPS) with potent immunostimulatory activity is recognized by the receptor complex of MD-2 and Toll-like receptor 4. Crystal structures of human MD-2 and its complex with the antiendotoxic tetra-acylated lipid A core of LPS have been determined at 2.0 and 2.2 angstrom resolutions, respectively. MD-2 shows a deep hydrophobic cavity sandwiched by two beta sheets, in which four acyl chains of the ligand are fully confined. The phosphorylated glucosamine moieties are located at the entrance to the cavity. These structures suggest that MD-2 plays a principal role in endotoxin recognition and provide a basis for antiseptic drug development. PubMed: 17569869DOI: 10.1126/science.1139111 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.21 Å) |
Structure validation
Download full validation report
